Ma, C. X., Luo, J., Naughton, M., Ademuyiwa, F., Suresh, R., Griffith, M., . . . Ellis, M. J. (2015). A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer. Clin Cancer Res.
Stile di citazione ChicagoMa, Cynthia X., et al. "A Phase 1 Trial of BKM120 (Buparlisib) in Combination With Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive Metastatic Breast Cancer." Clin Cancer Res 2015.
Citazione MLAMa, Cynthia X., et al. "A Phase 1 Trial of BKM120 (Buparlisib) in Combination With Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive Metastatic Breast Cancer." Clin Cancer Res 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.